Analysts Have Conflicting Sentiments on These Healthcare Companies: Joint (JYNT) and Kiora Pharmaceuticals (KPRX)

Joint (JYNT)

Maxim Group analyst Anthony Vendetti maintained a Hold rating on Joint yesterday. The company’s shares closed last Friday at $8.33.

According to TipRanks.com, Vendetti is ranked 0 out of 5 stars with an average return of -20.5% and a 26.9% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as NeuroOne Medical Technologies, Nexalin Technology, Inc., and SeaStar Medical Holding.

Joint has an analyst consensus of Moderate Buy, with a price target consensus of $12.00, implying a 47.8% upside from current levels. In a report released yesterday, TipRanks – PerPlexity also reiterated a Hold rating on the stock with a $8.50 price target.

See today’s best-performing stocks on TipRanks >>